• Coordination of produce food safety practices and sustainable and/or organic production methods
Seeing that organic produced food is not necessarily safe food and does not cover all the food safety elements, nor occupational health and safety (OHS) issues, GLOBALG.A.P is working with IFOAM and others on an interpretation guideline for organic GLOBALG.A.P production. This guideline will help to explain which points are not applicable or how an organic producer can comply. Another project under way is the development of add-on modules for food safety ad OHS issues to an organic inspection.
• Coordination of produce food safety practices and Federal, state, local and tribal government statutes and regulations
GLOBALG.A.P requires that producers comply with local legislation at all times. For this reason a US National Interpretation Working Group has been established that firstly looked at the GLOBALG.A.P standards from a “language” perspective. The second task would be to incorporate links to the relevant statutes and regulations to help producers to be able to comply. Where possible, a website which lists all the relevant legislation to primary production would be a great benefit to producers.
• Microbial testing
This is something that should NOT be required to be performed by producers. Implementing and understanding the principles of the guidance document should be sufficient to negate the need for ad-hoc microbial testing of products/hands/facilities on farm. Of course it is a tool that can be used to show corrective action is working.
• Strategies to enhance compliance.
Encouragement to producers from buyers to adopt third party certification is a proven strategy to enhance compliance. Incentives from the public sector such as reduced costs for public inspection, i.e. by offering online access on the certification status to public sector agencies, combined with market recognition would be powerful incentives to drive compliance.
GLOBALG.A.P would be very happy to provide further information and/or receive future FDA consultations
Contact point is : email@example.com